Tag: neurological disorders
EMVision’s neuroimaging advancements fueled by $15.28M from Keysight Technologies
EMVision Medical Devices Limited announced a strategic AUD 15.28 million investment from Keysight Technologies Inc, to bolster the former's neuroimaging technology and its potential to revolutionise diagnosis and treatment outcomes for neurological disorders.
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
